The full Diabetes 2022 scientific program across 2 days — keynotes, oral presentations, and posters. Talks are ordered by program prominence within each day.
Day 1
- Keynote
Heart failure management; a perspective from diabetes care
Baruch Itzhak · Tel Aviv University, Israel
People with type 2 diabetes (T2DM) are recognized as having a 2–4 times increased risk of heart failure (HF). Ambulatory diabetes care has long concentrated on the prevention of microvascular and arterial disease, and…
- Oral · In-Person
Epidemiological profile of diabetes, northeast, Haiti, 2017-2021
Kensly Flecher · Field Epidemiology Training Program (FETP), Haiti
Background : According to the WHO, diabetes is a public health problem. Its prevalence continues to increase over the years. The number of cases has increased worldwide from 108 million in 1980 to 537 million in 2021.…
- Oral
Role of the abscisic acid/LANCL system in glycemic control: A promising aid to combat diabetes and related metabolic syndrome
Laura Sturla · University of Genova, Italy
Abscisic acid (ABA) is an isoprenoid hormone with a very long evolutionary history and the only known hormone common to the vegetal and animal kingdoms, with a conserved role as a signal regulating cell responses to…
- Oral
Gestational diabetes is associated with a distinct urinary metabolomic signature in the latter half of pregnancy
Aisling Murphy · University of California, United States
Introduction: Gestational diabetics (GD) have both impaired insulin sensitivity and secretion, which may lead to perturbations in multiple metabolic pathways. Currently, screening paradigms for gestational diabetes…
- Oral
Microsomal triglyceride transfer protein regulates intracellular lipolysis in adipocytes independent of its lipid transfer activity
Sujith Rajan · NYU Long Island School of Medicine, United States
Background: The triglyceride (TG) transfer activity of microsomal triglyceride transfer protein (MTP) is essential for lipoprotein assembly in the liver and intestine; however, its function in adipose tissue, which does…
Day 2
- Keynote
Metal ion dyshomeostasis and coagulatory defects in diabetes
Alan J Stewart · University of St. Andrews, United Kingdom
Diabetes is a term used to describe a group of conditions that impact upon the body’s ability to control blood glucose levels. In type-I diabetes (T1DM), the β-cells in the pancreas responsible for producing insulin are…
- Keynote
Indicaxanthin from opuntia ficus indica fruit ameliorates glycidic metabolism and counteracts insulin resistance in high-fat-diet-fed mice
Mario Allegra · University of Palermo, Italy
Dysmetabolic conditions related to insulin-resistance (IR) are amongst the most common cause of death globally and their primary prevention has become a compelling goal of public health-oriented strategies. In recent…
- Keynote
Blood sugar fasting, post prandial and HbA1c level co-relationship in the management of diabetes mellitus.
Ashok Sharma · Indraprastha Apollo Hospital, India
Objectives There are only three main markers for the diagnosis and management of diabetes Mellitus. Fasting and post prandial blood sugar level gives the amount of glucose present during single point of time. On the…
- Keynote
Computer assisted quantifiable diagnostic tool for diabetic retinopathy
Jan Nemcansky · Charles University, Czech Republic
Rising prevalence of diabetic retinopathy (DR) and diabetic macular edema represents significant burden in the society and raises challenges both in establishing effective screening and in enlargening the screening…
- Keynote
Functional roles of dietary fibres from selected agricultural by-products in lowering glycemic index values of foods
Wan Rosli Wan Ishak · Universiti Sains Malaysia, Malaysia
Statement of the Problem: Presently, the prevalence of non-communicable diseases is increasingly growing with the number of diabetic people expected to increase from 171 million in 2000 to 366 million in 2030. This is…
- Oral
Activity tracker to increase motivation for physical activity in patients with Type 2 diabetes in primary care: A hybrid type 1 study
Caroline Rheaume · Laval University, Canada
According to the World Health Organization, diabetes is the direct cause of 1.5 million deaths annually. The adoption of healthy lifestyles, such as regular and consistent physical activity, plays an important role in…
- Oral
Advanced course: GLP-1 agonists - The future of diabetes research and clinical treatments
William A Seeds · SSRP Institute, United States
Heart disease remains the number leading cause of death year after year. The increased risk factors are certainly related to cardiovascular conditions but are also significantly attributable to metabolic disease states.…
- Oral
Diabetes management in spinal surgery
Brandon Lucke Wold · University of Florida, United States
Diabetes mellitus can lead to long-standing complications in multiple arenas. An area that is often overlooked is implications for major surgery. Spinal decompression and fusions have unique challenges in the diabetic…
- Oral
Metformin, pioglitazone, liraglutide and exenatide differentially affect metabolic and hormonal profiles in polycystic ovary syndrome: Cross-sectional study
Wenjing Hu · Chongqing Prevention and treatment Hospital for Occupational Diseases, China
Background and aims: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting up to 13% of women of reproductive age. Although the underlying pathogenesis of PCOS has not been fully understood…
- Oral
An insight view on herbal and alternative remediesused in the treatment of diabetes mellitus
Rupesh K Gautam · Amity Institute of Pharmacy, India
Diabetes is a major public health concern that has been progressively rising worldwide. This disease is associated with a high rate of mortality, morbidity, and long-term consequences and remains a significant risk…
- Oral
Epidemiological profile of diabetes in the south department from 2015 to 2021, Haiti
Berger Saintius · Field Epidemiology Training Program (FETP), Haiti
Background: Diabetes is an incurable chronic disease caused by a deficiency or failure to use insulin leading to excess sugar in the blood. According to the WHO, diabetes remains a real public health problem, despite…
- Oral
Statistical profile of new case of diabetes in the department of grand'anse 2020-2022, Haiti
Olguine Artiste · Field Epidemiology Training Program (FETP), Haiti
Diabetes sweet is defined by elevation chronicle of the concentration of glucose in the blood, to fasting 1.26 g/L or > 2g / L whatever collection time in presence of symptoms clinics, there are 2 types of diabetes…
- Oral
Serum haptoglobin is associated with obesity and lipids in mexicans
Miguel Vazquez Moreno · Mexican Social Security Institute, Mexico
Background . Haptoglobin is an acute-phase inflammatory protein mainly produced by the liver. Although recent literature evidence that rs2000999 in the HP gene is associated with total cholesterol (TC) and low-density…
- Poster
Endocrinological teleconsultation as a strategy in the brazilian public health system: randomized clinical trial
Daniela Laranja Gomes Rodrigues · Hospital Alemão Oswaldo Cruz, Brazil
Brazil has approximately 20 million people with Diabetes Mellitus. Early identification and treatment should be a concern of public authorities, to improve glycemic control and reduce it`s deleterious impacts on the…
- Poster
Reducing blood sugar level by ascending or descending the hexose sugar into nontoxic high or low carbon sugars or through superimposing glucose mirror image sugars by shaking it into a 12 carbon sugar, in vivo
Ravi Kikar Sinha · Indian Private Researcher, India
Organic Chemists and Biochemist's attention is brought to the task of searching for enzymes and procedures to affect in vivo enzymatic ascending or descending glucose sugars into nontoxic high or low carbon sugars or in…
Present your research at Diabetes 2027
Abstract submissions for the 2027 program are open · October 25–27, 2027 · Double Tree by Hilton Orlando Downtown, Orlando.
Join the Diabetes 2027 delegation
Orlando · October 25–27, 2027· Hybrid · in-person & virtual
Attend without presenting.
